# Protalix BioTherapeutics, Inc.: Form 8-K, filed Dec 23, 2024

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2024-12-23
- Accepted by EDGAR: Dec 23, 2024, 12:01 ET
- Period: 2024-12-23
- Accession: 0001558370-24-016445
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837024016445/plx-20241223x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837024016445/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837024016445/plx-20241223x8k.htm

Filed Dec 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-016445. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.